Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Toxoplasmosis Diagnostic Testing Market Size Growth Rate by Type: 2018 VS 2022 VS 2033
1.2.2 Indirect Immune Fluorescent Test (IFAT)
1.2.3 Modified Agglutination Test (MAT)
1.2.4 Enzyme-Linked Immunosorbent Assay (ELISA)
1.2.5 Immunoglobulin Tests
1.3 Market by Application
1.3.1 Global Toxoplasmosis Diagnostic Testing Market Growth by Application: 2018 VS 2022 VS 2033
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Diagnostic Laboratories
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Toxoplasmosis Diagnostic Testing Market Perspective (2018-2033)
2.2 Toxoplasmosis Diagnostic Testing Growth Trends by Region
2.2.1 Global Toxoplasmosis Diagnostic Testing Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 Toxoplasmosis Diagnostic Testing Historic Market Size by Region (2018-2023)
2.2.3 Toxoplasmosis Diagnostic Testing Forecasted Market Size by Region (2024-2033)
2.3 Toxoplasmosis Diagnostic Testing Market Dynamics
2.3.1 Toxoplasmosis Diagnostic Testing Industry Trends
2.3.2 Toxoplasmosis Diagnostic Testing Market Drivers
2.3.3 Toxoplasmosis Diagnostic Testing Market Challenges
2.3.4 Toxoplasmosis Diagnostic Testing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Toxoplasmosis Diagnostic Testing Players by Revenue
3.1.1 Global Top Toxoplasmosis Diagnostic Testing Players by Revenue (2018-2023)
3.1.2 Global Toxoplasmosis Diagnostic Testing Revenue Market Share by Players (2018-2023)
3.2 Global Toxoplasmosis Diagnostic Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Toxoplasmosis Diagnostic Testing Revenue
3.4 Global Toxoplasmosis Diagnostic Testing Market Concentration Ratio
3.4.1 Global Toxoplasmosis Diagnostic Testing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Toxoplasmosis Diagnostic Testing Revenue in 2022
3.5 Toxoplasmosis Diagnostic Testing Key Players Head office and Area Served
3.6 Key Players Toxoplasmosis Diagnostic Testing Product Solution and Service
3.7 Date of Enter into Toxoplasmosis Diagnostic Testing Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Toxoplasmosis Diagnostic Testing Breakdown Data by Type
4.1 Global Toxoplasmosis Diagnostic Testing Historic Market Size by Type (2018-2023)
4.2 Global Toxoplasmosis Diagnostic Testing Forecasted Market Size by Type (2024-2033)
5 Toxoplasmosis Diagnostic Testing Breakdown Data by Application
5.1 Global Toxoplasmosis Diagnostic Testing Historic Market Size by Application (2018-2023)
5.2 Global Toxoplasmosis Diagnostic Testing Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Toxoplasmosis Diagnostic Testing Market Size (2018-2033)
6.2 North America Toxoplasmosis Diagnostic Testing Market Growth Rate by Country: 2018 VS 2022 VS 2033
6.3 North America Toxoplasmosis Diagnostic Testing Market Size by Country (2018-2023)
6.4 North America Toxoplasmosis Diagnostic Testing Market Size by Country (2024-2033)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Toxoplasmosis Diagnostic Testing Market Size (2018-2033)
7.2 Europe Toxoplasmosis Diagnostic Testing Market Growth Rate by Country: 2018 VS 2022 VS 2033
7.3 Europe Toxoplasmosis Diagnostic Testing Market Size by Country (2018-2023)
7.4 Europe Toxoplasmosis Diagnostic Testing Market Size by Country (2024-2033)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Toxoplasmosis Diagnostic Testing Market Size (2018-2033)
8.2 Asia-Pacific Toxoplasmosis Diagnostic Testing Market Growth Rate by Region: 2018 VS 2022 VS 2033
8.3 Asia-Pacific Toxoplasmosis Diagnostic Testing Market Size by Region (2018-2023)
8.4 Asia-Pacific Toxoplasmosis Diagnostic Testing Market Size by Region (2024-2033)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Toxoplasmosis Diagnostic Testing Market Size (2018-2033)
9.2 Latin America Toxoplasmosis Diagnostic Testing Market Growth Rate by Country: 2018 VS 2022 VS 2033
9.3 Latin America Toxoplasmosis Diagnostic Testing Market Size by Country (2018-2023)
9.4 Latin America Toxoplasmosis Diagnostic Testing Market Size by Country (2024-2033)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Toxoplasmosis Diagnostic Testing Market Size (2018-2033)
10.2 Middle East & Africa Toxoplasmosis Diagnostic Testing Market Growth Rate by Country: 2018 VS 2022 VS 2033
10.3 Middle East & Africa Toxoplasmosis Diagnostic Testing Market Size by Country (2018-2023)
10.4 Middle East & Africa Toxoplasmosis Diagnostic Testing Market Size by Country (2024-2033)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Abbott
11.1.1 Abbott Company Detail
11.1.2 Abbott Business Overview
11.1.3 Abbott Toxoplasmosis Diagnostic Testing Introduction
11.1.4 Abbott Revenue in Toxoplasmosis Diagnostic Testing Business (2018-2023)
11.1.5 Abbott Recent Development
11.2 Thermo Fisher Scientific
11.2.1 Thermo Fisher Scientific Company Detail
11.2.2 Thermo Fisher Scientific Business Overview
11.2.3 Thermo Fisher Scientific Toxoplasmosis Diagnostic Testing Introduction
11.2.4 Thermo Fisher Scientific Revenue in Toxoplasmosis Diagnostic Testing Business (2018-2023)
11.2.5 Thermo Fisher Scientific Recent Development
11.3 Bio-Rad
11.3.1 Bio-Rad Company Detail
11.3.2 Bio-Rad Business Overview
11.3.3 Bio-Rad Toxoplasmosis Diagnostic Testing Introduction
11.3.4 Bio-Rad Revenue in Toxoplasmosis Diagnostic Testing Business (2018-2023)
11.3.5 Bio-Rad Recent Development
11.4 Danaher
11.4.1 Danaher Company Detail
11.4.2 Danaher Business Overview
11.4.3 Danaher Toxoplasmosis Diagnostic Testing Introduction
11.4.4 Danaher Revenue in Toxoplasmosis Diagnostic Testing Business (2018-2023)
11.4.5 Danaher Recent Development
11.5 Biomerica
11.5.1 Biomerica Company Detail
11.5.2 Biomerica Business Overview
11.5.3 Biomerica Toxoplasmosis Diagnostic Testing Introduction
11.5.4 Biomerica Revenue in Toxoplasmosis Diagnostic Testing Business (2018-2023)
11.5.5 Biomerica Recent Development
11.6 Biotest
11.6.1 Biotest Company Detail
11.6.2 Biotest Business Overview
11.6.3 Biotest Toxoplasmosis Diagnostic Testing Introduction
11.6.4 Biotest Revenue in Toxoplasmosis Diagnostic Testing Business (2018-2023)
11.6.5 Biotest Recent Development
11.7 GenBio
11.7.1 GenBio Company Detail
11.7.2 GenBio Business Overview
11.7.3 GenBio Toxoplasmosis Diagnostic Testing Introduction
11.7.4 GenBio Revenue in Toxoplasmosis Diagnostic Testing Business (2018-2023)
11.7.5 GenBio Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Toxoplasmosis Diagnostic Testing Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2033
Table 2. Key Players of Indirect Immune Fluorescent Test (IFAT)
Table 3. Key Players of Modified Agglutination Test (MAT)
Table 4. Key Players of Enzyme-Linked Immunosorbent Assay (ELISA)
Table 5. Key Players of Immunoglobulin Tests
Table 6. Global Toxoplasmosis Diagnostic Testing Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2033
Table 7. Global Toxoplasmosis Diagnostic Testing Market Size by Region (US$ Million): 2018 VS 2022 VS 2033
Table 8. Global Toxoplasmosis Diagnostic Testing Market Size by Region (2018-2023) & (US$ Million)
Table 9. Global Toxoplasmosis Diagnostic Testing Market Share by Region (2018-2023)
Table 10. Global Toxoplasmosis Diagnostic Testing Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 11. Global Toxoplasmosis Diagnostic Testing Market Share by Region (2024-2033)
Table 12. Toxoplasmosis Diagnostic Testing Market Trends
Table 13. Toxoplasmosis Diagnostic Testing Market Drivers
Table 14. Toxoplasmosis Diagnostic Testing Market Challenges
Table 15. Toxoplasmosis Diagnostic Testing Market Restraints
Table 16. Global Toxoplasmosis Diagnostic Testing Revenue by Players (2018-2023) & (US$ Million)
Table 17. Global Toxoplasmosis Diagnostic Testing Market Share by Players (2018-2023)
Table 18. Global Top Toxoplasmosis Diagnostic Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Toxoplasmosis Diagnostic Testing as of 2022)
Table 19. Ranking of Global Top Toxoplasmosis Diagnostic Testing Companies by Revenue (US$ Million) in 2022
Table 20. Global 5 Largest Players Market Share by Toxoplasmosis Diagnostic Testing Revenue (CR5 and HHI) & (2018-2023)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Toxoplasmosis Diagnostic Testing Product Solution and Service
Table 23. Date of Enter into Toxoplasmosis Diagnostic Testing Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Toxoplasmosis Diagnostic Testing Market Size by Type (2018-2023) & (US$ Million)
Table 26. Global Toxoplasmosis Diagnostic Testing Revenue Market Share by Type (2018-2023)
Table 27. Global Toxoplasmosis Diagnostic Testing Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 28. Global Toxoplasmosis Diagnostic Testing Revenue Market Share by Type (2024-2033)
Table 29. Global Toxoplasmosis Diagnostic Testing Market Size by Application (2018-2023) & (US$ Million)
Table 30. Global Toxoplasmosis Diagnostic Testing Revenue Market Share by Application (2018-2023)
Table 31. Global Toxoplasmosis Diagnostic Testing Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 32. Global Toxoplasmosis Diagnostic Testing Revenue Market Share by Application (2024-2033)
Table 33. North America Toxoplasmosis Diagnostic Testing Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 34. North America Toxoplasmosis Diagnostic Testing Market Size by Country (2018-2023) & (US$ Million)
Table 35. North America Toxoplasmosis Diagnostic Testing Market Size by Country (2024-2033) & (US$ Million)
Table 36. Europe Toxoplasmosis Diagnostic Testing Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 37. Europe Toxoplasmosis Diagnostic Testing Market Size by Country (2018-2023) & (US$ Million)
Table 38. Europe Toxoplasmosis Diagnostic Testing Market Size by Country (2024-2033) & (US$ Million)
Table 39. Asia-Pacific Toxoplasmosis Diagnostic Testing Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2033
Table 40. Asia-Pacific Toxoplasmosis Diagnostic Testing Market Size by Region (2018-2023) & (US$ Million)
Table 41. Asia-Pacific Toxoplasmosis Diagnostic Testing Market Size by Region (2024-2033) & (US$ Million)
Table 42. Latin America Toxoplasmosis Diagnostic Testing Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 43. Latin America Toxoplasmosis Diagnostic Testing Market Size by Country (2018-2023) & (US$ Million)
Table 44. Latin America Toxoplasmosis Diagnostic Testing Market Size by Country (2024-2033) & (US$ Million)
Table 45. Middle East & Africa Toxoplasmosis Diagnostic Testing Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 46. Middle East & Africa Toxoplasmosis Diagnostic Testing Market Size by Country (2018-2023) & (US$ Million)
Table 47. Middle East & Africa Toxoplasmosis Diagnostic Testing Market Size by Country (2024-2033) & (US$ Million)
Table 48. Abbott Company Detail
Table 49. Abbott Business Overview
Table 50. Abbott Toxoplasmosis Diagnostic Testing Product
Table 51. Abbott Revenue in Toxoplasmosis Diagnostic Testing Business (2018-2023) & (US$ Million)
Table 52. Abbott Recent Development
Table 53. Thermo Fisher Scientific Company Detail
Table 54. Thermo Fisher Scientific Business Overview
Table 55. Thermo Fisher Scientific Toxoplasmosis Diagnostic Testing Product
Table 56. Thermo Fisher Scientific Revenue in Toxoplasmosis Diagnostic Testing Business (2018-2023) & (US$ Million)
Table 57. Thermo Fisher Scientific Recent Development
Table 58. Bio-Rad Company Detail
Table 59. Bio-Rad Business Overview
Table 60. Bio-Rad Toxoplasmosis Diagnostic Testing Product
Table 61. Bio-Rad Revenue in Toxoplasmosis Diagnostic Testing Business (2018-2023) & (US$ Million)
Table 62. Bio-Rad Recent Development
Table 63. Danaher Company Detail
Table 64. Danaher Business Overview
Table 65. Danaher Toxoplasmosis Diagnostic Testing Product
Table 66. Danaher Revenue in Toxoplasmosis Diagnostic Testing Business (2018-2023) & (US$ Million)
Table 67. Danaher Recent Development
Table 68. Biomerica Company Detail
Table 69. Biomerica Business Overview
Table 70. Biomerica Toxoplasmosis Diagnostic Testing Product
Table 71. Biomerica Revenue in Toxoplasmosis Diagnostic Testing Business (2018-2023) & (US$ Million)
Table 72. Biomerica Recent Development
Table 73. Biotest Company Detail
Table 74. Biotest Business Overview
Table 75. Biotest Toxoplasmosis Diagnostic Testing Product
Table 76. Biotest Revenue in Toxoplasmosis Diagnostic Testing Business (2018-2023) & (US$ Million)
Table 77. Biotest Recent Development
Table 78. GenBio Company Detail
Table 79. GenBio Business Overview
Table 80. GenBio Toxoplasmosis Diagnostic Testing Product
Table 81. GenBio Revenue in Toxoplasmosis Diagnostic Testing Business (2018-2023) & (US$ Million)
Table 82. GenBio Recent Development
Table 83. Research Programs/Design for This Report
Table 84. Key Data Information from Secondary Sources
Table 85. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Toxoplasmosis Diagnostic Testing Market Size Comparison by Type (2023-2033) & (US$ Million)
Figure 2. Global Toxoplasmosis Diagnostic Testing Market Share by Type: 2022 VS 2033
Figure 3. Indirect Immune Fluorescent Test (IFAT) Features
Figure 4. Modified Agglutination Test (MAT) Features
Figure 5. Enzyme-Linked Immunosorbent Assay (ELISA) Features
Figure 6. Immunoglobulin Tests Features
Figure 7. Global Toxoplasmosis Diagnostic Testing Market Size Comparison by Application (2023-2033) & (US$ Million)
Figure 8. Global Toxoplasmosis Diagnostic Testing Market Share by Application: 2022 VS 2033
Figure 9. Hospitals Case Studies
Figure 10. Clinics Case Studies
Figure 11. Diagnostic Laboratories Case Studies
Figure 12. Others Case Studies
Figure 13. Toxoplasmosis Diagnostic Testing Report Years Considered
Figure 14. Global Toxoplasmosis Diagnostic Testing Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 15. Global Toxoplasmosis Diagnostic Testing Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 16. Global Toxoplasmosis Diagnostic Testing Market Share by Region: 2022 VS 2033
Figure 17. Global Toxoplasmosis Diagnostic Testing Market Share by Players in 2022
Figure 18. Global Top Toxoplasmosis Diagnostic Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Toxoplasmosis Diagnostic Testing as of 2022)
Figure 19. The Top 10 and 5 Players Market Share by Toxoplasmosis Diagnostic Testing Revenue in 2022
Figure 20. North America Toxoplasmosis Diagnostic Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 21. North America Toxoplasmosis Diagnostic Testing Market Share by Country (2018-2033)
Figure 22. United States Toxoplasmosis Diagnostic Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 23. Canada Toxoplasmosis Diagnostic Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 24. Europe Toxoplasmosis Diagnostic Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 25. Europe Toxoplasmosis Diagnostic Testing Market Share by Country (2018-2033)
Figure 26. Germany Toxoplasmosis Diagnostic Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 27. France Toxoplasmosis Diagnostic Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 28. U.K. Toxoplasmosis Diagnostic Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 29. Italy Toxoplasmosis Diagnostic Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 30. Russia Toxoplasmosis Diagnostic Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 31. Nordic Countries Toxoplasmosis Diagnostic Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 32. Asia-Pacific Toxoplasmosis Diagnostic Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 33. Asia-Pacific Toxoplasmosis Diagnostic Testing Market Share by Region (2018-2033)
Figure 34. China Toxoplasmosis Diagnostic Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 35. Japan Toxoplasmosis Diagnostic Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 36. South Korea Toxoplasmosis Diagnostic Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 37. Southeast Asia Toxoplasmosis Diagnostic Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 38. India Toxoplasmosis Diagnostic Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 39. Australia Toxoplasmosis Diagnostic Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 40. Latin America Toxoplasmosis Diagnostic Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 41. Latin America Toxoplasmosis Diagnostic Testing Market Share by Country (2018-2033)
Figure 42. Mexico Toxoplasmosis Diagnostic Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 43. Brazil Toxoplasmosis Diagnostic Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 44. Middle East & Africa Toxoplasmosis Diagnostic Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 45. Middle East & Africa Toxoplasmosis Diagnostic Testing Market Share by Country (2018-2033)
Figure 46. Turkey Toxoplasmosis Diagnostic Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 47. Saudi Arabia Toxoplasmosis Diagnostic Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 48. Abbott Revenue Growth Rate in Toxoplasmosis Diagnostic Testing Business (2018-2023)
Figure 49. Thermo Fisher Scientific Revenue Growth Rate in Toxoplasmosis Diagnostic Testing Business (2018-2023)
Figure 50. Bio-Rad Revenue Growth Rate in Toxoplasmosis Diagnostic Testing Business (2018-2023)
Figure 51. Danaher Revenue Growth Rate in Toxoplasmosis Diagnostic Testing Business (2018-2023)
Figure 52. Biomerica Revenue Growth Rate in Toxoplasmosis Diagnostic Testing Business (2018-2023)
Figure 53. Biotest Revenue Growth Rate in Toxoplasmosis Diagnostic Testing Business (2018-2023)
Figure 54. GenBio Revenue Growth Rate in Toxoplasmosis Diagnostic Testing Business (2018-2023)
Figure 55. Bottom-up and Top-down Approaches for This Report
Figure 56. Data Triangulation
Figure 57. Key Executives Interviewed